Supporting Parents of Children With Type 1 Diabetes: Experiment Comparing Message and Delivery Types

Bree Holtz1, Katharine Mitchell1

  • 1Department of Advertising and Public Relations, College of Communication Arts and Sciences, Michigan State University, East Lansing, MI, United States.

JMIR Formative Research
|February 3, 2023
PubMed

Insights

Providing diabetes-specific messages to parents of children with Type 1 diabetes (T1D) improved disease management and satisfaction. The delivery method, whether Facebook or SMS, did not impact outcomes.

Area of Science:

  • Pediatric Endocrinology
  • Behavioral Science
  • Health Communication

Background:

  • Type 1 diabetes (T1D) affects over 154,000 children in the US, placing a significant care burden on parents.
  • Effective parental support is crucial for managing T1D in children.
  • Existing support strategies require further investigation for optimal delivery.

Purpose of the Study:

  • To evaluate the impact of diabetes-specific versus general parenting messages on parents of children with T1D.
  • To compare the effectiveness of Facebook and SMS text messaging as delivery channels for informational support.
  • To assess changes in diabetes behaviors, parental satisfaction, and quality of life.

Main Methods:

  • A pilot study involving 102 parents of children with T1D was conducted over 8 weeks.
  • A 2x2 experimental design tested message type (diabetes-specific vs. general parenting) and delivery medium (Facebook vs. SMS).
  • Outcomes measured included diabetes behavior, informational support, emotional support, and quality of life.

Main Results:

  • Parents receiving diabetes-specific messages showed significant improvements in diabetes behaviors (P=.05).
  • Participants in the diabetes message groups reported higher satisfaction with the intervention (P=.005).
  • No significant differences were found between message types or delivery mediums for informational support, emotional support, or quality of life.

Conclusions:

  • Informational support via Facebook or SMS text messaging does not significantly impact parents' perceptions of social support or quality of life.
  • Diabetes-specific messages enhance disease management and parental satisfaction compared to general parenting messages.
  • Findings offer guidance for developing targeted social support interventions for parents managing childhood T1D.
Abstract

Related Concept Videos

Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.9K
Insulin Formulations: Types and Delivery01:27

Insulin Formulations: Types and Delivery

Insulin preparations are categorized by their duration of action into short-acting and long-acting types. Two strategies are used to modify insulin's absorption and pharmacokinetic profile: slowing the absorption post-subcutaneous injection, or altering human insulin's amino acid sequence or protein structure. These changes retain the insulin's ability to bind to the insulin receptor, but alter its behavior in solution or after injection.
Short-acting insulins are divided into...
247
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.6K
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
224
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
326
Drug Delivery: Parenteral Route01:29

Drug Delivery: Parenteral Route

The parenteral route is a critical method of drug administration. It delivers compounds directly into the systemic circulation and bypasses the gastrointestinal tract. This approach is particularly advantageous for drugs that exhibit poor absorption or instability when administered orally.
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
701